NDA 22432, held by Questcor Pharma. Repository Corticotropin.
As of Nov 14, 2026, NDA 22432 (H.P. Acthar Gel), held by Questcor Pharma, was first approved by FDA on Oct 15, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 15, 2010 | Original applicationTYPE 6 · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| H.P. Acthar Gel80 UNITS/ML · injectable; injection | Repository Corticotropin | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
